FFA
INDV icon

Farther Finance Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Farther Finance Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$130K Buy
3,624
+3,180
+716% +$120K ﹤0.01% 2649
2026
Q2 		$18.2K Buy
444
+116
+35% +$4.21K ﹤0.01% 4043
2026
Q1 		$10.1K Sell
328
-290
-47% -$9.58K ﹤0.01% 4111
2025
Q4 		$22.2K Buy
618
+603
+4,020% +$18.4K ﹤0.01% 3372
2025
Q3 		$362 Buy
+15
New +$314 ﹤0.01% 4615
2025
Q1 		– Sell
-1,840
Closed -$22.9K – 4338
2024
Q4 		$22.9K Hold
1,840
– – ﹤0.01% 2028
2024
Q3 		$17.9K Hold
1,840
– – ﹤0.01% 2133
2024
Q2 		$29K Hold
1,840
– – ﹤0.01% 1635
2024
Q1 		$38.7K Buy
+1,840
New +$34.6K ﹤0.01% 1269

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's INDV Position: Q3 2026 in Review

Farther Finance Advisors increased its Indivior Pharmaceuticals (INDV) stake by 716% in Q3 2026, buying an estimated $120K and bringing the position to 3,624 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Farther Finance Advisors first reported a position in INDV in Q1 2024 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • Farther Finance Advisors held 3,624 shares of Indivior Pharmaceuticals worth $130K as of Q3 2026.
  • Farther Finance Advisors bought 3,180 Indivior Pharmaceuticals shares in Q3 2026, an estimated $120K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2649 holding.
  • Farther Finance Advisors first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.